🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Don't miss out on early registration savings for #AANSC! Register before June 1 to get the best rate: bit.ly/40KS0WJ #NeuroTwitter #Neurology

Thanks to all the hard work of our team here at Mayo, we were able to uncover a novel motor association area in the depths of the central sulcus, disrupting our nearly century-old understanding of the organization of the primary motor cortex. nature.com/articles/s4159…

Just out: our paper in stiff-person spectrum disorder (SPSD) diagnosis, misdiagnosis and suggested diagnostic criteria! Eoin Flanagan Nick Zalewski Divyanshu Dubey onlinelibrary.wiley.com/doi/full/10.10…

Any thoughts on these proposed criteria?

I hope you'll join us in Minneapolis - if you ever see Neuroligy patients in the hospital, this conference is for you! #Neurotwitter American Academy of Neurology #AANSC23

Reminder: Advance registration for #AANSC ends June 29! Register now to save: bit.ly/40KS0WJ #Neurology #NeuroTwitter

Neurology Podcast: Drs. Stacey Clardy & Jonathan Graff-Radford discuss everything we need to know about corticobasal syndrome. Listen now: bit.ly/3pJLwdG Read the related article in Neurology: bit.ly/3rc4cD1 Stacey Clardy MD PhD Jonathan Graff-Radford #NeuroTwitter

Clinicoradiologic and Neuropathologic Evaluation of Corticobasal Syndrome: bit.ly/43kcnL2 #NeuroTwitter #Neurology

Interested in attending #AANFC October 27-29? Get an overview with this video featuring Jonathan Graff-Radford and Leeann Garms. They cover what to expect and why you should attend: bit.ly/47qJUpY #Neurology #NeuroTwitter

Especially excited to see what Shadi Yaghi and Casey Albin, MD have in store for their microlearning session and here from Vijay Ramanan, MD PhD about Alzheimer therapeutics

New Study Published in Neurology Journal: Small Percentage of People with Early #Dementia Eligible for New #Alzheimers Drugs. bit.ly/47yBFZa #AlzheimersDisease #AANscience #Neurology

Vijay Ramanan, MD PhD, a co-author of the study and a clinical neurologist at Mayo Clinic in Rochester, Minnesota, said some clinicians may use the trial criteria as a “reasonable guidepost” when deciding which patients make the best candidates for the drugs.

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging pubmed.ncbi.nlm.nih.gov/37586881/

Don't miss out on early registration savings for #AANFC! Register by August 31 to get the best rate: bit.ly/44jBNsH #NeuroTwitter #Neurology

Did you know that we added an Anti-Amyloid Therapy Boot Camp to this year's #AANFC? Join us in person or online, October 27-29, so you don't miss it. Register by end of day today, August 31, to receive the greatest savings! bit.ly/44KkvpD #Neurology #NeuroTwitter

Shout out to Dr. Cliatt Brown, pictured below! She's in our #CognitiveDisorders Division🧠📚 #LoveU2024 #UGivingDay

AAN Summer Conference on Autoimune Neurology Registration is NOW OPEN!! Sign up Now -🔥🧠(Don't delay on this one!) aan.com/conferences-co…

It’s not too late to take part in the #neurology meeting of the year virtually! There’s still time to join us online for top-tier education, the latest breaking science, and access to neurology’s brightest minds. Register now: bit.ly/49ajOZt #NeuroTwitter

Join Derek Stitt, M.D., Lyell Jones MD, @FarwaAli_, Elizabeth Coon, MD, Chia-Chun Chiang, MD, Radhika Dhamija, MD, FACMG, FAAN🧬🧠👶, Divyanshu Dubey, Eoin Flanagan, Jonathan Graff-Radford, @StuMcCarter, Rafid Mustafa, Vijay Ramanan, MD PhD, Beth Robertson, Maisha Robinson, Kelsey Smith, MD, Deena Tajfirouz, MD and more at

The median time interval between becoming Tau PET positive and developing dementia is ~7 years and no T+ participant remained dementia-free after 15 years.